SCHEMBL16159693

SCHEMBL16159693

c1cc(-c2ccc3cc(-c4cccc(-c5ncco5)n4)ccc3c2)nc(-c2ncco2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.45
MAPT P10636 3/20 0.40
KDM4E B2RXH2 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
ALDH1A1 P00352 2/20 0.40
HSD17B10 Q99714 2/20 0.40
LMNA P02545 2/20 0.40
TP53 P04637 2/20 0.40
PKM P14618 1/20 0.40
TSHR P16473 1/20 0.40
KLF5 Q13887 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HPGDS O60760 1/20 0.39
CCNC P24863 2/20 0.38
CDK8 P49336 2/20 0.38
POLB P06746 2/20 0.36
HPGD P15428 2/20 0.36
RAB9A P51151 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17704349 0.89 HPGDS (0.38) LTA4HMAPTKDM4ESMN1; SMN2ALDH1A1
SCHEMBL315001 0.86 HPGDS (0.44) LTA4HKDM4ESMN1; SMN2ALDH1A1HSD17B10
SCHEMBL16159710 0.84 LTA4H (0.41) LTA4HMAPTKDM4ESMN1; SMN2ALDH1A1
SCHEMBL16159439 0.81 CCNC (0.36) LTA4HHPGDSCCNCCDK8HPGD
SCHEMBL26260185 0.80 LTA4H (0.55) LTA4HMAPTKDM4ESMN1; SMN2ALDH1A1
SCHEMBL17704334 0.80 SMN1; SMN2 (0.40) LTA4HMAPTKDM4ESMN1; SMN2ALDH1A1
SCHEMBL16159285 0.79 LTA4H (0.51) LTA4HMAPTKDM4ESMN1; SMN2ALDH1A1
SCHEMBL16159444 0.79 PDK2 (0.42) LTA4HHPGDSCCNCCDK8HPGD
SCHEMBL16159740 0.79 HPGDS (0.40) LTA4HMAPTKDM4ESMN1; SMN2HPGDS
SCHEMBL8929882 0.79 HPGDS (0.40) LTA4HKDM4ESMN1; SMN2ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160118598-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME JNC CORPORATION (JP) 2016-04-28 US disclosed
US-20160118598-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME JNC CORPORATION (JP) 2016-04-28 US disclosed
WO-2014163173-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME JNC株式会社 (JP) 2014-10-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160118598-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME HVCN1, VDAC1, SLC26A3 LTA4H 1673/4885MAPT 3871/4885KDM4E 629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.